RedHill seeks to collaborate with pharmaceutical companies with a proven R&D track record and strong commercial capabilities. Currently, RedHill has two partnerships, one with Gaelan Medical Trade for Talicia® in the United Arab Emirates (UAE) and with Hyloris Pharmaceuticals for RHB-102 (Bekinda®) for worldwide development and commercialization outside North America, further expanding its global reach and impact.
RedHill is seeking commercialization and development partners for its products in the U.S. and worldwide.
RedHill also seeks to in-license or acquire FDA approved products, marketed in the U.S., in the therapeutic areas of gastrointestinal diseases, primary care and other indications.
If you are interested in exploring partnering, licensing and business development opportunities with RedHill, please contact:
Adi Frish, Chief Corporate & Business Development Officer
Tel.: +972 (0)3 541 3138
bd@redhillbio.com
Upcoming Events & Presentations
For upcoming conferences and meetings, please visit the Investors section.